Chronic Myeloid Leukemia in a Patient Receiving Tofacitinib: A Case Report and Literature Review

Background. Tofacitinib is a new oral Janus kinase inhibitor that has shown promising clinical benefit in various rheumatologic diseases. However, many concerns related to the development of malignancies have been reported with its use. Case Presentation. A 43-year-old female patient received tofaci...

Full description

Saved in:
Bibliographic Details
Main Authors: Georgio Medawar, Joseph Chahrouri, Rabih Said
Format: Article
Language:English
Published: Wiley 2019-01-01
Series:Case Reports in Rheumatology
Online Access:http://dx.doi.org/10.1155/2019/2814504
Tags: Add Tag
No Tags, Be the first to tag this record!